CFD’er er komplekse instrumenter, og der er en stor risiko forbundet med disse for at miste penge på grund af gearing. 74.2 % af detailinvestorerne har tab på deres konto, når de handler CFD’er med denne udbyder.Du skal overveje, om du forstår, hvordan CFD’er fungerer, og om du har råd til at løbe en stor risiko for at miste dine penge.

Close

Handel Bayer BAYGn

Bayer live diagram

Grundlæggende Instrumenter

Weekly Search
Weekly
Daily
Dato Luk Ændring % Ændre Åbn Høj Lav

Seneste nyheder

Frances Wang 2025 Mar 31, 16:00

Gold Prices Hit New Highs: What is Gold CFD trading?

Commodities
Frances Wang 2025 Mar 31, 16:00

Oil Markets Today: Oil Falls on OPEC+ Output Hike and Trump’s Tariffs

Commodities
Tommy Yap 2025 Mar 29, 16:00

Week Ahead: U.S. Non-Farm Payrolls Coming Up: What to Expect

Forex Indices
Frances Wang 2025 Mar 27, 16:00

Stock market today: S&P 500, Dow, Nasdaq slip on Trump's tariff escalation

Indices
Frances Wang 2025 Mar 27, 16:00

Forex news today: EUR/USD Struggles to Gain Traction Amid Tariff Threats

Forex
Tommy Yap 2025 Mar 27, 16:00

Morning Note: U.K. Retail Sales, U.S. Core PCE & Canada GDP Outlook

Morning Note Forex
Tommy Yap 2025 Mar 26, 16:00

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Morning Note USD CAD Cryptocurrencies
Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed

Info

Spread

0.15

Spread (%)

0.6739 %

Gearing

1:5

Dag til dag-rente Køb

-0.0556 %

Dag til dag-rente Sælg

-0.0333 %

Valuta

EUR

Åbningstider for handel

Market lukket

Onsdag

07:02 - 10:59

Mandag

07:02-10:59

Mandag

11:04-15:29

Tirsdag

07:02-10:59

Tirsdag

11:04-15:29

Torsdag

07:02-10:59

Torsdag

11:04-15:29

Fredag

07:02-10:59

Fredag

11:04-15:29

Analyse og statistikker

Åbn

---

Forrige luk

---

52 uger høj/lav

--- – ---

Markedsværdi

21682098176

Aktier udestående

982424000

Indtjeningsdato (Næste)

2018-06-06

Udbytteprocent

Ex-udbyttedato

2025-04-28

Forventet årlig udbyttesats

0.11

Forventet årlig udbytteprocent

0.0049

EPS

-2.6

Få mere at vide om dette instrument

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed management as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular, renal, and gynecological diseases; collaboration agreement with Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Relaterede instrumenter

Aktiv
Sælge
Køb
% Ændre
Relaterede instrumenter
Trustpilot